RankingsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Provision for income taxes

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1.16T
P/E ratio
12.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 2025-6,024-26.40%
Mar 31, 2024-8,185-116.77%
Mar 31, 202348,794+15.19%
Mar 31, 202242,361+3.26%
Mar 31, 202141,022-14.59%
Mar 31, 202048,029+192.52%
Mar 31, 201916,419-4.43%
Mar 31, 201817,180-5.74%
Mar 31, 201718,226+22.63%
Mar 31, 201614,863-18.81%
Mar 31, 201518,307

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)